C-CS7VRegeneration Biomedical
autologous stem cells, Wnt activation, intracerebral delivery
replacementreplacingcell therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-CS7V
C-CS7VC-CS7Vautologous stem cells, Wnt activation, intracerebral delivery
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Regeneration Biomedical autologous stem cells, Wnt activation, intracerebral delivery
Regeneration Biomedical, Inc. is based in Newport Beach, CA and is in the clinical research stage of developing treatments for neurodegenerative diseases. Its technique uses highly purified, Wnt-activated autologous stem cells injected directly into the brain to bypass the blood brain barrier. The company states it has completed a Phase 1 clinical trial in Alzheimer's disease patients and expects Phase 2 recruitment to begin soon.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Regeneration Biomedical — Translational · Bottom quartile. Derived deterministically from 2 extracted project(s). Most-advanced status: phase 2. Band: translational. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic